Search Results

There are 21420 results for: content related to: Introduction to symposium on vascular biology, metabolism and cancer

  1. You have free access to this content
    Mechanisms of resistance to vascular endothelial growth factor blockade

    Cancer

    Volume 118, Issue 14, 15 July 2012, Pages: 3455–3467, Shaad E. Abdullah and Roman Perez-Soler

    Version of Record online : 15 NOV 2011, DOI: 10.1002/cncr.26540

  2. You have free access to this content
    Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration

    Acta Ophthalmologica

    Volume 92, Issue 8, December 2014, Pages: 713–723, Geoffrey K. Broadhead, Thomas Hong and Andrew A. Chang

    Version of Record online : 12 JUN 2014, DOI: 10.1111/aos.12463

  3. You have full text access to this OnlineOpen article
    Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma

    EMBO Molecular Medicine

    Volume 8, Issue 1, January 2016, Pages: 39–57, Alexander Scholz, Patrick N Harter, Sebastian Cremer, Burak H Yalcin, Stefanie Gurnik, Maiko Yamaji, Mariangela Di Tacchio, Kathleen Sommer, Peter Baumgarten, Oliver Bähr, Joachim P Steinbach, Jörg Trojan, Martin Glas, Ulrich Herrlinger, Dietmar Krex, Matthias Meinhardt, Astrid Weyerbrock, Marco Timmer, Roland Goldbrunner, Martina Deckert, Christian Braun, Jens Schittenhelm, Jochen T Frueh, Evelyn Ullrich, Michel Mittelbronn, Karl H Plate and Yvonne Reiss

    Version of Record online : 14 DEC 2015, DOI: 10.15252/emmm.201505505

  4. You have free access to this content
    Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy

    Cancer

    Volume 103, Issue 8, 15 April 2005, Pages: 1561–1570, Anthony D. Yang, Todd W. Bauer, E. Ramsay Camp, Ray Somcio, Wenbiao Liu, Fan Fan and Lee M. Ellis

    Version of Record online : 7 MAR 2005, DOI: 10.1002/cncr.20942

  5. You have free access to this content
    Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway

    Cancer

    Volume 121, Issue 2, January 15, 2015, Pages: 311–319, Ole-Petter R. Hamnvik, Toni K. Choueiri, Alexander Turchin, Rana R. McKay, Lipika Goyal, Michael Davis, Marina D. Kaymakcalan and Jonathan S. Williams

    Version of Record online : 18 SEP 2014, DOI: 10.1002/cncr.28972

  6. You have free access to this content
    Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review

    Clinical & Experimental Ophthalmology

    Volume 44, Issue 4, May/June 2016, Pages: 335–339, Hemal Mehta, Mark C Gillies and Samantha Fraser-Bell

    Version of Record online : 28 APR 2016, DOI: 10.1111/ceo.12757

  7. Plaque neovascularization: defense mechanisms, betrayal, or a war in progress

    Annals of the New York Academy of Sciences

    Volume 1254, Issue 1, April 2012, Pages: 7–17, Pedro R. Moreno, Meeranani Purushothaman and K-Raman Purushothaman

    Version of Record online : 30 APR 2012, DOI: 10.1111/j.1749-6632.2012.06497.x

  8. Anti-VEGF therapy: riding the wave of change

    Clinical & Experimental Ophthalmology

    Volume 36, Issue 5, July 2008, Pages: 401–402, Alex P Hunyor

    Version of Record online : 24 AUG 2008, DOI: 10.1111/j.1442-9071.2008.01801.x

  9. You have free access to this content
    Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion

    Acta Ophthalmologica

    Volume 93, Issue 6, September 2015, Pages: e465–e468, Shunsuke Yasuda, Shu Kachi, Shinji Ueno, Chang-Hua Piao and Hiroko Terasaki

    Version of Record online : 18 JAN 2015, DOI: 10.1111/aos.12674

  10. You have free access to this content
    Retinal artery occlusion following intravitreal anti-VEGF therapy

    Acta Ophthalmologica

    Volume 88, Issue 2, March 2010, Pages: 263–266, Therese Von Hanno, Bettina Kinge and Kristian Fossen

    Version of Record online : 16 APR 2009, DOI: 10.1111/j.1755-3768.2008.01406.x

  11. You have free access to this content
    Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment

    Acta Ophthalmologica

    Volume 92, Issue 1, February 2014, Pages: e50–e56, Christoph R. Clemens, Nina Bastian, Florian Alten, Carolin Milojcic, Peter Heiduschka and Nicole Eter

    Version of Record online : 2 JUL 2013, DOI: 10.1111/aos.12234

  12. You have free access to this content
    Anti VEGF

    Acta Ophthalmologica

    Volume 92, Issue s253, September 2014, Page: 0, C POURNARAS

    Version of Record online : 20 AUG 2014, DOI: 10.1111/j.1755-3768.2014.2613.x

  13. You have free access to this content
    Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment

    Journal of Internal Medicine

    Volume 276, Issue 2, August 2014, Pages: 140–153, C. M. G. Cheung and T. Y. Wong

    Version of Record online : 21 MAR 2014, DOI: 10.1111/joim.12227

  14. You have free access to this content
    Short-term progression of wet AMD and correlation with 1-year treatment results

    Acta Ophthalmologica

    Volume 90, Issue 6, September 2012, Pages: e420–e427, Marion Munk, Christopher Kiss, Florian Sulzbacher, Stefan Eisenkölbl, Stefan Sacu, Klaudius Kalcher, Lee Jampol and Ursula Schmidt-Erfurth

    Version of Record online : 17 FEB 2012, DOI: 10.1111/j.1755-3768.2011.02353.x

  15. You have full text access to this OnlineOpen article
    Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality

    EMBO Molecular Medicine

    Volume 7, Issue 4, April 2015, Pages: 368–379, Alan McIntyre and Adrian L Harris

    Version of Record online : 19 FEB 2015, DOI: 10.15252/emmm.201404271

  16. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis

    Clinical & Experimental Ophthalmology

    Volume 42, Issue 7, September/October 2014, Pages: 637–649, Shuangwen Zhou, Jianping Gao and Xun Xu

    Version of Record online : 27 JAN 2014, DOI: 10.1111/ceo.12286

  17. Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models

    The Journal of Pathology

    Volume 227, Issue 4, August 2012, Pages: 417–430, Mallika Singh, Suzana S Couto, William F Forrest, Anthony Lima, Jason H Cheng, Rafael Molina, Jason E Long, Patricia Hamilton, Angela McNutt, Ian Kasman, Michelle A Nannini, Hani Bou Reslan, Tim C Cao, Calvin CK Ho, Kai H Barck, Richard AD Carano, Oded Foreman, Jeffrey Eastham-Anderson, Adrian M Jubb, Napoleone Ferrara and Leisa Johnson

    Version of Record online : 28 JUN 2012, DOI: 10.1002/path.4053

  18. You have free access to this content
    Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration

    Acta Ophthalmologica

    Volume 92, Issue 8, December 2014, Pages: e610–e614, Agnieszka Kubicka-Trząska, Joanna Wilańska, Bożena Romanowska-Dixon and Marek Sanak

    Version of Record online : 6 MAY 2014, DOI: 10.1111/aos.12435

  19. You have free access to this content
    Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion

    Intervention Review

    The Cochrane Library

    Tasanee Braithwaite, Afshan A Nanji, Kristina Lindsley and Paul B Greenberg

    Published Online : 1 MAY 2014, DOI: 10.1002/14651858.CD007325.pub3

  20. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia

    Intervention Review

    The Cochrane Library

    Ying Zhu, Ting Zhang, Gezhi Xu and Lijun Peng

    Published Online : 15 DEC 2016, DOI: 10.1002/14651858.CD011160.pub2